FDA outlines product development process to combat Wuhan coronavirus
The FDA on Monday issued a statement explaining how the agency can facilitate the development of investigational products to diagnose, treat and prevent emerging public health threats such as the novel coronavirus (2019-nCoV) that emerged in Wuhan, China in December.
“We are actively leveraging the vast breadth of the FDA’s expertise and have begun employing the full range of our public health authorities to facilitate the development and availability of investigational medical products to address this urgent public health situation,” said FDA Commissioner Stephen Hahn.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.